These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 22019794

  • 1. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis.
    Deshpande A, Pant C, Pasupuleti V, Rolston DD, Jain A, Deshpande N, Thota P, Sferra TJ, Hernandez AV.
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):225-33. PubMed ID: 22019794
    [Abstract] [Full Text] [Related]

  • 2. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.
    Trifan A, Stanciu C, Girleanu I, Stoica OC, Singeap AM, Maxim R, Chiriac SA, Ciobica A, Boiculese L.
    World J Gastroenterol; 2017 Sep 21; 23(35):6500-6515. PubMed ID: 29085200
    [Abstract] [Full Text] [Related]

  • 3. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.
    Stevens V, Dumyati G, Brown J, Wijngaarden E.
    Pharmacoepidemiol Drug Saf; 2011 Oct 21; 20(10):1035-42. PubMed ID: 21833992
    [Abstract] [Full Text] [Related]

  • 4. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
    Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA.
    Arch Intern Med; 2010 May 10; 170(9):772-8. PubMed ID: 20458084
    [Abstract] [Full Text] [Related]

  • 5. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting.
    Dalton BR, Lye-Maccannell T, Henderson EA, Maccannell DR, Louie TJ.
    Aliment Pharmacol Ther; 2009 Mar 15; 29(6):626-34. PubMed ID: 19183143
    [Abstract] [Full Text] [Related]

  • 6. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
    Barletta JF, El-Ibiary SY, Davis LE, Nguyen B, Raney CR.
    Mayo Clin Proc; 2013 Oct 15; 88(10):1085-90. PubMed ID: 24012413
    [Abstract] [Full Text] [Related]

  • 7. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D, Young LR, Reddy S, Bergman C, Young JD.
    J Hosp Infect; 2016 Feb 15; 92(2):173-7. PubMed ID: 26616410
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile Infection: a meta-analysis.
    Deshpande A, Pasupuleti V, Rolston DD, Jain A, Deshpande N, Pant C, Hernandez AV.
    Clin Infect Dis; 2011 Oct 15; 53(7):e81-90. PubMed ID: 21890762
    [Abstract] [Full Text] [Related]

  • 12. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
    King RN, Lager SL.
    Pharmacotherapy; 2011 Jul 15; 31(7):642-8. PubMed ID: 21923450
    [Abstract] [Full Text] [Related]

  • 13. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
    Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M, Talmor D.
    Arch Intern Med; 2010 May 10; 170(9):784-90. PubMed ID: 20458086
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection.
    Cao F, Chen CX, Wang M, Liao HR, Wang MX, Hua SZ, Huang B, Xiong Y, Zhang JY, Xu YL.
    J Hosp Infect; 2018 Jan 10; 98(1):4-13. PubMed ID: 28842261
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
    Giuliano C, Wilhelm SM, Kale-Pradhan PB.
    Expert Rev Clin Pharmacol; 2012 May 10; 5(3):337-44. PubMed ID: 22697595
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis.
    Arriola V, Tischendorf J, Musuuza J, Barker A, Rozelle JW, Safdar N.
    Infect Control Hosp Epidemiol; 2016 Dec 10; 37(12):1408-1417. PubMed ID: 27677811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.